RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on the stock to $132 from the previous $108.

In a report released on January 17, Jon Arfstrom from RBC Capital maintained a Buy rating on Webster Financial (WBS – Research Report), with a

Morgan Stanley analyst Robert Koh maintained a Buy rating on AGL Energy Limited (AGLNF – Research Report) today and set a price target of

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the important fact that global interest in Canadian bonds remains high,

“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets

T-Mobile Us Inc (TMUS) stock saw a modest uptick, ending the day at $218.97 which represents a slight increase of $3.22 or 1.49% from the prior close of $215.75. The stock opened at $219.21 and touched a low of $217.

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $14.13 which represents a decrease of $-0.64 or -4.33% from the prior close of $14.77. The stock opened at $14.89 and touched a low of $14.

Wells Fargo CEO Charlie Scharf validates some of the optimism, telling analysts he feels "really great about our progress." But he said executives "don't want to get ahead of ourselves."

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

U.S. stock trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.